Aberdeen Group
RARE icon

Aberdeen Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Aberdeen Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$807K Sell
38,499
-1,431,452
-97% -$32.2M ﹤0.01% 846
2025
Q4 		$33.8M Buy
1,469,951
+496,295
+51% +$16.3M 0.05% 292
2025
Q3 		$29.3M Buy
973,656
+472,600
+94% +$14.2M 0.05% 323
2025
Q2 		$18.2M Buy
501,056
+22,152
+5% +$799K 0.03% 440
2025
Q1 		$17.3M Buy
478,904
+161,779
+51% +$6.73M 0.03% 432
2024
Q4 		$13.3M Buy
317,125
+63,821
+25% +$3.17M 0.03% 450
2024
Q3 		$14.1M Sell
253,304
-31,441
-11% -$1.6M 0.03% 456
2024
Q2 		$11.7M Buy
284,745
+143,628
+102% +$6.13M 0.02% 483
2024
Q1 		$6.59M Hold
141,117
– – 0.01% 621
2023
Q4 		$6.75M Buy
+141,117
New +$5.47M 0.01% 620

Other funds holding RARE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return